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Summary 
Here we report the presence of a trans-sialidase on the surface of Trypanosoma brucei culture- 
derived procyclic trypomastigotes.  The enzyme is not detected in lysates of bloodstream try- 
pomastigotes enriched for either stumpy or slender forms. The trans-sialidase catalyzes the transfer 
of ot(2-3)-linked sialic acid residues to lactose./3-galactopyranosyl  residues are at least 100 times 
better acceptors for sialic acid than ot-galactopyranosyl  residues. In the absence of efficient acceptors, 
the purified enzyme transfers sialic acid to water, i.e., it acts as a sialidase. Although the T. cruzi 
and T. brucei trans-sialidases have very similar donor and acceptor specificities,  they are antigenicaUy 
distinct. Sodium dodecyl sulfate--polyacramide gel electrophoresis under nonreducing conditions 
and silver staining of the purified trans-sialidase reveals a single band of 63 kD. When the surface 
membrane of live procyclic trypomastigotes is trans-sialylated, using radioactive sialyllactose as 
the donor substrate,  it appears that the only sialylated surface molecule is procyclin. Pronase 
treatment of live parasites removes only part of the surface sialic acid, in agreement with recent 
data showing that the glycosylphosphatidylinositol  anchor of procyclin is sialylated (Ferguson, 
M. A. J.,  M. Murray,  H.  Rutherford, and M. J. McConville.  1993. Biochern. J.  In press). 
ry  panosoma brucei has a complex life cycle that involves 
traceUular multiplication in body fluids of mammalian 
hosts, and in the gut and salivary glands of the insect vector, 
the tsetse fly (1). During transformation from bloodstream 
trypomastigotes to insect procyclic trypomastigotes, the para- 
sites undergo biochemical and morphological changes. Within 
48 h of their ingestion by the fly, bloodstream trypomastigotes 
shed  their  surface  coat,  the  variant  surface glycoprotein 
(VSG), 1 and replace it with the procyclic acidic repetitive 
protein (PAR.P, or procyclin) (2-5). Both VSG and procyclin 
are anchored to the plasma membrane by glycosylphospha- 
tidylinositol (GPI) (6, 7). VSG represents a parasite adapta- 
tion to life in the mammalian host, providing it with a mech- 
anism to escape from immune effector mechanisms (1). The 
1 Abbreviations used in this patxot: BSM, buffered semidefined medium; GPI, 
glycosylphosphatidylinositol;  VSG, variant surface glycoprotein. 
function of the antigenically conserved (3, 8) T. brucei procy- 
clin is unknown. 
Recent data document a striking difference between the 
structure of the GPI anchor of procyclin and that of most 
other membrane proteins (including VSG) (9), i.e., the procy- 
clin GPI anchor contains sialic acid (9a). Sialylated molecules 
have also been identified on the surface membrane of try- 
pomastigotes  of Trypanosoma cruzi  (10). The sialic acid of 
T. cruzi is not synthesized by the parasite, but transferred from 
extrinsic host-derived macromolecules in a reaction catalyzed 
by an unusual trans-sialidase (10). 
In this paper we investigate the origin of the sialic acid 
of T. brucei procyclic trypomastigotes.  We demonstrate that 
the transformation of T. brucei blood trypomastigotes into 
culture-derived  forms is associated with the expression of a 
trans-sialidase sharing several  characteristics with the T. cruzi 
enzyme and, in addition, that procyclin is the main endoge- 
nous sialic acid acceptor. 
465  J. Exp. Med. ￿9  The Rockefeller University Press ￿9 0022-1007/93/02/0465/10  $2.00 
Volume 177  February  1993  465--474 Materials and Methods 
Parasites.  The TREU 667 stock of T. brucei brucei (11) was used. 
Procyclic trypomastigotes were  grown in buffered  semidefined 
medium (BSM) (12) containing 10% FCS (HyClone Laboratories, 
Logan,  UT)  at  26~  Bloodstream  trypomastigotes  enriched 
85-90% for slender or stumpy forms (13) were purified from blood 
of infected rats by anion exchange chromatography (14). Y strain 
T. cruzi trypomastigotes (15) were from LIC-MKz cell cultures 
(CCb7;  American Type Culture Collection, Rockville,  MD) in 
DME containing 10%  FCS, as described previously (10). 
Sialic Acid Measurement.  This was done on: (a) untreated cell-de- 
rived T. cruzi trypomastigotes or T. brucei procyclics; (b) procyclics 
treated with sialidase (see below);  (c) procyclics first treated with 
Vibrio cholera sialidase and then with either 1 mM c~(2-3)-sialyl- 
lactose (Boehringer Mannheim Biochemicals, Indianapolis, IN) or 
c~(2-6)- sialyllactose (Sigma Chemical Co., St. Louis, MO) in BSM 
containing 0.1% gelatin (Bio-Rad Laboratories, Richmond, CA) 
(BSM-G), for 40 min at 26~  (d) procyclics treated with pronase 
(see below); and (e) supernatants of pronase-treated procyclics. The 
parasites were washed six times with cold BSM-G and incubated 
in 0.1 M sulfuric acid for I h at 80~  before being assayed for sialic 
acid by the HPLC-thiobarbituric method (16). 
Enzyme Assays.  Trans-sialidase activity was assayed as previ- 
ously described by measuring the transfer of sialic acid from sialyl- 
lactose to radioactive lactose (10). Briefly, samples were assayed in 
a total volume of 50/~1 of 20 mM Hepes, pH 7 (Sigma Chemical 
Co.), containing 50 nmol of c~(2-3)-sialyllactose  and 0.36 nmol of 
[D-glucose-l-14C]hctose (60 Ci/mol) (Amersham Corp., Arlington 
Heights, IL). This mixture was incubated for 40 rain at room tem- 
perature and the reaction terminated by the addition of 1 ml of 
water and passage through a 0.5-ml QAE-Sephadex A50 column 
preequilibrated with water, which retains the sialylhctose and allows 
lactose to elute.  Under these conditions, the formation of radio- 
labeled sialyllactose was linear with respect to enzyme concentra- 
tions.  Activity was  expressed  as cpm  (bound  sialyl[14C]1actose) 
eluted from the columns with 0.5 ml of 1 M ammonium formate 
solution. In some assays, the sialyl(cc2-3)lactose  was substituted with 
0.25-25 nmol of sialyl(c~2-6)lactose (Boehringer Mannheim Bin- 
chemicals), sialyl(c~2-9)sialyl(~2-3)lactose-ceramide  (kindly supplied 
by Dr.  A.  Hasegawa,  Gifu University,  Gifu, Japan),  N-acetyl- 
neuraminic acid, colominic acid, or 4-methylumbelliferyl-N-acetyl- 
neuraminic acid (Sigma Chemical Co.) to test their potential ability 
to serve as sialic acid donors.  In other assays, 40-4,000  nmol of 
lactose, stachyose, melibiose, Gal(B1-6)Gal,  ~-methyl-D-galacto- 
pyranoside,/~-methyl-D-gahctopyranoside  (Sigma Chemical Co.), 
Gal(~l-4)[Fuc(ccl-3)]Glc  (Oxford Glycosystems,  Inc.,  ILosedale, 
NY), or 10/~M of cupric nitrate or mercuric acetate were added 
to the reaction mixture to assess their possible ability to serve as 
sialic acid acceptors or trans-sialidase inhibitors. Results from these 
latter assays were expressed as the percentage of cpm reduction in 
relation to control reactions carried out in the absence of nonradi- 
oactive saccharides or inhibitors. 
Trans-sialidase activity was also demonstrated by measuring the 
transfer  of [3H]sialic acid residues from sialyllactose to different 
saccharides. [Sialic-9-3H](c~2-3)-sialyllactose was prepared  by in- 
cubating 25/~1  of [sialic-9-3H]CMP-sialic acid (26.2  Ci/mmol; 
NEN Research Products, Boston, MA) with 0.15 M lactose in the 
presence of porcine submaxillary c~(2-3)-Gal~(1-3)-GalNac sialyl- 
transferase (17). 15 nmol of the labeled sialyllactose and 100 nmol 
of potential sialic acid acceptors were incubated for 210 min at room 
temperature in 15 #1 of 20 mM Hepes, pH 7, in the presence of 
purified trans-sialidase. The products of the reactions were isolated 
by elution from QEAE-Sephadex columns as described above, lyophi- 
lized, and subjected to TLC on silica gel 60 phtes (Macherey-Nagel, 
Dtiren, Germany) using ethanol, n-butanol, pyridine, water, acetic 
acid (100:10:10:30:3 [vol/vol]).  The sialylated compounds were 
visualized by spraying the TLC plates with EN3HANCE (NEN 
Research Products),  followed by fluorography.  Saccharide purity 
was assessed  by silica-gel TIC analysis of 1-/~mol samples, followed 
by staining with the orcinol-ferric chloride reagent (18). Single bands 
were observed with melibiose, ol(2-3)sialyllactose, c~-methylgalac- 
tose, ~-methylgalactose,  and Gal(/31-6)Gal. 
Sialidase activity was determined by measuring the fluorescence 
of 4-methylumbelliferone resulting from the hydrolysis of 4-methyl- 
umbelliferyl-N-acetylneuramim'c  acid (initial concentration of I mM 
in 50/zl of 20 mM Hepes buffer, pH 6.7), as described elsewhere (19). 
Immunoprecipitation.  Parasites  were lysed in 1.5% NP-40, 50mM 
Tris-HC1, pH 7.4,  1 mM PMSF, and 5/~g/ml of antipain, pep- 
statin, and leupeptin  (1 ml/109 parasites). The lysates were cleared 
by centrifugation at 10,000 g for 5 min at 4~  40-/xl fractions 
of the lysates were incubated, with mixing, for 1 h at 4~  with 
3, 9, and 27/~1 of protein A-agarose (Sigma Chemical Co.) bearing 
adsorbed mAb 39 (anti-T. cruzi trans-sialidase [19]). 80-/~1 volumes 
of lysate were similarly incubated with protein A-agarose-bearing 
polyclonal  antibodies  against  purified  T. cruzi  trans-sialidase  or 
against  a synthetic peptide  corresponding to the first  19 NH2- 
terminal amino acid residues of the T cruz/trans-sialidase (20). These 
antibodies were from rabbits immunized intramuscularly with 60 
/~g of purified  T. cruzi trans-sialidase (19), or with 1 mg of syn- 
thetic peptide coupled to KLH (Sigma Chemical Co.) (21), in CFA, 
followed by two subcutaneous  boosters  of the same antigens in 
IFA, at 21-d intervals. 
In addition, lysates were prepared from T. brucm'  radiolabeled with 
[3H]sialic acid residues  (see below) in the presence of 1%  BSA 
(Ultrapure;  Boehringer Mannheim Biochemicals).  These lysates 
were mixed with equal volumes of 1 M Tris/HC1,  pH 8.6,  2% 
BSA, and left for 30 min at 56~  to inactivate trans-sialidaseAiali- 
dase activities. 60-/zl fractions of these lysates were incubated with 
20/zl of protein A-agarose bearing 20/zg of mAb 137 (IgG1 anti- 
procydin; kindly supplied by Dr. T. Pearson, University of Victoria, 
Victoria,  Canada [3]) or 20/zg of mAb 3C9 (IgG1 anti- T. cruzi 
Ssp-3 [22]) for 40 min at 4~  The beads were then centrifuged, 
washed three times with 50 mM Tris/HC1, pH 8.6, 285 mM NaC1, 
0.3% BSA, and the bound antigen was eluted with 0.1 M HC1/gly- 
cine, pH 3.1. The amount of radioactivity remaining in the ex- 
tracts and in the eluates from the beads was measured in a ~ counter. 
Enzyme Purification.  Trans-sialidase was purified from trypo- 
mastigote lysates, prepared as described above, by af~nity chroma- 
tography on Con A-Sepharose (Pharmacia-LKB Biotechnology, Inc., 
Piscataway, NJ), followed by anion-exchange chromatography on 
a Mono-Q FPIC HR5/5 column (Pharmacia-LKB Biotechnology, 
Inc.),  as described for the T. cruzi trans-sialidase (19). A sample 
of the purified enzyme was concentrated on a Centriprep-10  con- 
centrator (Amicon Corp., Beverly, MA) and further subjected to 
sizing chromatography on Superose 12 HR 10/30 and 6 HR 10/30 
columns (Pharmacia-LKB Biotechnology, Inc.), connected in se- 
ries (19), and preequilibrated  with 40 mM Tris/HC1,  pH 8, con- 
taining 0.1%  NP-40. 
Protease and Sialidase Treatment.  Trypomastigotes  were washed 
once with BSM and treated with 250/~g/ml of trypsin (Sigma 
Chemical Co.) in DME for 20 min at 37~  or with 1,250 U/ml 
of pronase (Calbiochem-Behring Corp., San Diego, CA) in DME 
for either 15 min at 37~  or 30 rain at room temperature,  as indi- 
cated in the text. The trypsin digestion was terminated by the ad- 
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Sigma Chemical Co.). The parasites were further washed in DME 
containing 2 mg/ml BSA and 100 tig/ml soybean trypsin inhib- 
itor. Pronase was removed by the addition of 50 vol of ice-cold 
DME containing 30% FCS followed by washing with DME con- 
taining 15% FCS,  at 4~  NP-40 lysates of the protease-treated 
parasites  were assayed for trans-sialidase  activity. In controls, the 
trypsin was added to parasites in the presence of soybean trypsin 
inhibitor, or the pronase added to the parasites concomitantly with 
the addition of the DME with FCS. In addition,  the assays for 
trans-sialidase  activity in lysates containing pronase were done at 
4~  in the presence of 60 mg/ml of BSA. 
Trans-sialidase, partially purified by Con A affinity chromatog- 
raphy, was treated with 100 #g/ml of proteinase K (Sigma Chem- 
ical Co.), 250 #g/ml of trypsin, or 1,250 U/ml of pronase in DME 
for 20 min at 37~  The proteinase K and the trypsin digestions 
were,  respectively,  terminated by the  addition  of either PMSF 
(2 mM) and BSA (20 mg/ml), or soybean trypsin inhibitor (500 
#g/ml) and BSA (30 mg/ml). After pronase digestion, BSA (60 
mg/ml) was added to the reaction mixture, and assays for trans- 
sialidase activity were performed immediately, at 4~  in the pres- 
ence of 75 mg/ml BSA. 
Trypomastigotes washed once with BSM-G were incubated for 
2 h  with 0.33 U/ml  V. cholera sialidase (Boehringer Mannheim 
Biochemicals)  in  BSM-G, pH  5.5,  and washed five times with 
BSM-G. Some lysate samples were incubated with equal volumes 
of I U/ml sialidase, or of sialidase buffer, for 15 min at 37~  be- 
fore being subjected  to SDS-PAGE (see below). 
Labeling of SuFface Components with Sialic Acid.  Trypomastigotes 
(1.5  x  108) were washed once with cold BSM-G, left for 2 h at 
26~  in BSM-G, washed four times more with cold BSM-G, and 
resuspended in 250/11 of BSM-G containing 45 nmol of [3H]sialyl- 
lactose. After a 25 min incubation at room temperature, 30 nmol 
of additional [3H]sialyllactose were added to the parasites and the 
incubation continued for 3 rain at room temperature. The trypo- 
mastigotes were then washed three times with cold BSM-G and 
lysed with NP-40 for SDS-PAGE and immunoprecipitation. 
SDS-PAGE and Western Blotting.  Samples of FPLC fractions, 
or of cell lysates containing the equivalent of 5  x  106 parasites 
labeled with [3H]sialic acid, were applied to 7.5% SDS-PAGE gels 
under both reducing and nonreducing conditions (23). Gels were 
either silver stained (24) or impregnated with 1 M sodium salicy- 
late (25),  stained  with coomassie blue,  and subjected  to fluorog- 
raphy using an intensifying screen. 
For Western blot analysis, separated  proteins were transferred 
to nitrocellulose membranes and probed with mAbs 39 and 137. 
Bound antibodies were detected with an alkaline-phosphatase  con- 
jugate. 
Results 
Presence of Sialic Acid in  T.  bmcei Procyclic Trypomastigotes. 
Initial experiments demonstrated the presence of sialic acid 
associated with the surface membrane of cultured, extensively 
washed  T. brucei procyclic trypomastigotes.  The total sialic 
acid content of parasite extracts, as compared with those of 
T. cruzi cell-derived trypomastigotes,  is shown  in Table  1. 
T. brucei contains more sialic acid than T. cruzi.  Most of the 
sialic acid is surface associated since it was removed from the 
live parasites by pronase or by sialidase treatment (Table 1). 
Enzymatic treatments did not affect the motility of the para- 
sites, as determined by light microscopy. These results, how- 
ever, do not address the question of the origin of the surface- 
bound sialic acid. To investigate its possible acquisition from 
Table  1.  Presence of Siatic Acid in T.  brucei Procyctic Trypomastigotes and Its Removal by Enzymatic  Treatment 
Amount of sialic acid 
Parasite  Treatments  Source of sialic acid  per 106 parasites* 
T.  brucei procyclics 
T. cruzi cell culture 
trypomastigotes 
pmol 
None  Parasite  lysate  177 
Sialidase*  Parasite  lysate  49 
Sialidase; Y-sialyllactoseS  Parasite lysate  163 
Sialiase; 6'-sialyllactoseS  Parasite lysate  71 
Pronase  Parasite  lysateU  38 
Supernatant~  82 
None  Parasite  lysate  22 
* As assessed by the thiobarbituric method and HPLC. 
* Trypomastigotes were washed once with BSM-G, incubated for 2 h at 26~  with 0.33 U/ml of V. cholera sialidase in BSM, pH 5.7, and washed 
five times with BSM-G. 
S Sialidase-treated  parasites were washed twice with BSM-G, incubated with 1 mM of sialyllactose in BSM-G for 40 min at 260C, and washed five 
times with BSM-G. 
MI Prepared from trypomastigotes that had been washed five  times with BSM, incubated for 30 min at room temperature with 1,250 U/ml of pronase 
in DME, pH 7.5, and washed once with BSM-G. 
I Containing material released by treating trypomastigotes with pronase. 
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Parasite species  Enzyme  source  No. of parasites*  Trans-sialidase activity* 
mean cpm 
T.  brucei  Procyclic trypomastigote  106  2,044 
lysate  3  x  106  5,300 
Slender bloodstream  106  3 
trypomastigote  lysate  107  - 6 
Stumpy bloodstream  106  8 
trypomastigote  lysate  107  15 
Procyclic trypomastigote 
culture supernatantS  -  253 
T. cruzi  Cell-derived trypomastigote 
lysate  106  11,186 
Cell-derived trypomastigote 
culture supernatantS  -  12,366 
" Total number of lysed parasites in the aliquot assayed. 
* All samples were assayed in duplicate; the background value (111 cpm, obtained in the absence of trans-sialidase) was subtracted. Variation be- 
tween the duplicate values was <7% of the mean (lysates) or <18.6% of the mean (culture supematant). 
s 30-#1 volumes of supernatants from a procyclic trypomastigote culture (107 parasites/ml), or from a Y-strain T. cruzi culture on LLC-MK2 cells 
(5  x  106 parasites/ml), were added to the reaction mixtures. 
exogenous sources, trypomastigotes were treated with siali- 
dase,  reincubated  for  30  min  at  room  temperature  with 
oe(2-3)-sialyUactose, and extensively washed. As shown in Table 
1, their sialic acid content was restored. When ol(2-6)-sialyl- 
lactose was substituted for ot(2-3)-sialyllactose, however, much 
less sialic acid was found on the parasites  (Table 1), indicating 
that the sialylation reaction is specific and documenting the 
efficiency of the washing procedure to remove remaining free 
sialic  acid,  or sialic  acid loosely bound to the parasites. 
Presence of T~ans-sialidase in T. brucei Procyclic Trywmastigotes. 
In the following experiments,  we assayed for the presence 
of trans-sialidase  in NP-40 extracts of T. brucei blood-stage 
slender and stumpy trypomastigotes, and of T. brucei procy- 
clic trypomastigotes.  Enzymatic  activity was measured by 
the ability to transfer sialic acid from sialyllactose to radio- 
labeled lactose,  forming  labeled sialyllactose.  As shown in 
Table 2, only the extracts of procyclics were active. The trans- 
sialidase activity per parasite was approximately six times less 
than  that  of Y  strain  cell-derived  77. cruzi trypomastigotes 
(Table 2). No significant activity was found in supernatants 
of procyclic cultures  (Table  2). 
Enzyme Purification.  NP-40 lysates of T. brucei procyclics 
were first subjected to Con A affinity chromatography and 
elution with ot-methyl-D-mannoside. Approximately 40% of 
the trans-sialidase  activity was recovered. This material was 
then subjected to anion-exchange FPLC. Most enzymatic ac- 
tivity was eluted between 70 and 130 mM of NaC1 (Fig.  1 
A), with a recovery of ,,o85%.  Reduced SDS-PAGE of this 
purified trans-sialidase  showed two major bands of 73 and 
77 kD, and a faint band of •48  kD (Fig. 1, B, inset, left lane). 
To assess the molecular mass of its native form and further 
purify the trans-sialidase,  Mono-Q fractions corresponding 
to the peak of enzymatic activity were pooled, concentrated 
by retention on a 10-kD-cutoff membrane filter, and subjected 
to sizing chromatography on FPLC Superose 12 and Superose 
6 columns connected in series. In several experiments, using 
different trans-sialidase  preparations, enzymatic activity was 
detected  in  fractions  corresponding  to  molecular  masses 
ranging from ~66 to >700 kD. In the experiment illustrated 
in Fig. 1 B, the two major broad active peaks have molecular 
masses of '~180 and ~660 kD. In another run, a 66-kD peak 
replaced the  180-kD peak (not  shown).  On one occasion, 
a fresh lysate produced only the 660-kD peak (not shown). 
These data suggest that  the trans-sialidase  has a propensity 
to self-aggregate. 
Reduced SDS-PAGE gels of fractions corresponding both 
to the 180- and 660-kD peaks,  stained by silver,  revealed  a 
major band of '~73 kD (Fig.  1 B, inset).  In the fraction cor- 
responding to the high molecular mass peak,  a less intense 
band of ~77 kD could also be seen. Two faint bands corre- 
sponding to molecular masses of "o63-67 kD could also be 
seen. Under nonreducing conditions, however, a single band 
of ~63  kD was observed (not  shown). 
Protease Sensitivity and Surface Localization of the Trans-sial- 
idase.  Con A-purified T. brucei trans-sialidase  was relatively 
resistant  to treatment  with  250/zg/ml  of trypsin or with 
468  A Novel Trans-sialidase of Trypanosoma brucei Figure  1.  Purification of the T. brucei trans-sialidase on FPLC columns. Trans-sialidase activity and OD at 280 nm of fractions are represented by 
solid and dotted lines, respectively. (A) Fractions ehted with an NaCI gradient from a Mono-Q column, preequilibrated with 20 mM Tris-HC1, pH 8, 
containing 0.1% NP-40. The input was an enzyme sample purified from an NP-40 lysate by Con A at~nity chromatography. The NaC1 gradient is 
represented by the dashed line. (B) Gel filtration on Superose 12-Superose 6 columns run in tandem of a sample of the T. brucei enzyme purified by 
the ion-exchange  chromatography described above. The inset shows the result of SDS-PAGE and silver staining of the input sample (left lane) and 
of the fractions indicated by the hatched arrows. The positions of molecular mass standards are shown on the right of the inset. 
100 #g/ml of proteinase K  for 20 min at 37~  Enzymatic 
activity was destroyed, however, by treatment with 1,250 U/ml 
of pronase (Table 3). Accordingly, treatment, of live parasites 
with  1,250 U/m1 of pronase for  15 min  at  37~  but  not 
with  250 #g/ml of trypsin for 20 min at  37~  markedly 
reduced the trans-sialidase activity of subsequently prepared 
lysates  (Table  3). 
Substrate Specificity.  The ability of  different sialylated corn- 
Table  3.  Protease  Sensitivity  and Su~ace  Localization  of the  T.  brucei Trans-sialidase 
Trans-sialidase  preparation  Treatment  Trans-sialidase  activity* 
Con A-purified enzyme* 
mean  cpn,/ 
None  2,130 
Trypsin  1,671 
Proteinase K  1,930 
Pronase  4 
Lysate of untreated  None  4,237 
procyclicsS 
Lysate of trypsin-treated  None  4,843 
procyclicslt 
Lysate of pronase-treated  None  1,616 
procyclicsS 
* Samples were tested at 4~  in duplicate. Variation between the duplicate values was in every case <8% of the mean. The background value 
(52 cpm, obtained in the absence of trans-sialidase) was subtracted. 
* An NP-40 lysate of procyclic trypomastigotes was incubated for 30 rain with Con A-Sepharose, the bound trans-sialidase eluted by overnight in- 
cubation with an excess of o~-methyl-n-mannoside  at 4~  and extensively dialyzed against cold PBS. The purified enzyme was tested without  treat- 
ment or after treatment with  250 #g/ml of trypsin or 100 #g/ml of proteinase K, followed by the addition of protease inhibitors and BSA. 
S Procyclic trypomastigotes were kept for 15 min at 37~  and then mixed with 1,250 U/ml of pronase. DME containing 30% FCS was immedi- 
ately added to the parasites, which were washed with  DME containing 15%  FCS and lysed with  NP-40 in the presence of 60 mg/ml of BSA. 
This lysate had the same level of trans-sialidase activity as a lysate containing no proteases. 
fl Procyclic trypomastigotes were treated with 250/zg/ml of trypsin for 20 min at 37~  At the end of the incubation, soybean trypsin inhibitor 
(STI) and BSA were added to the parasites, which were washed with  BSM containing BSA and STI and lysed with  NP-40. 
I Procyclic trypomastigotes were treated with  1,250 U/ml of pronase for 15 min at 37~  At the end of the incubation, DME containing 30% 
FCS was added to the parasites, which were washed with DME containing 15% FCS and lysed with NP-40 in the presence of 60 mg/ml of BSA. 
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Figure 2.  Ability  of different compounds to donate sialic acid to lactose 
in the presence of T. brucei (filled symbols) or T. cruzi (open symbols) trans- 
sialidases. ['4C]Lactose (0.36  nmol) was  incubated  with the indicated 
amounts of potential sialic acid donors and Con A-purified  T. brucei or 
T.  cruzi  trans-sialidases, as  described  in Materials  and  Methods.  (A) 
Sialyl(o~2-3)lactose (circles), sialyl(a2-6)lactose (triangles), and colominic 
acid (squares). (B) Sialyl(ol2-9)sialyl(ol2-3)lactose-ceramide  (circles), fetuin 
(triangles), and N-acetylneuraminic  acid (squares), 
pounds to serve as sialic acid donors for purified T. brucei and 
T cruzi trans-sialidases was assessed. Both enzymes catalyzed 
the transfer to radiolabeled lactose of sialic acid from o~(2-3)- 
sialyllactose,  fetuin  (Fig.  2),  and 4-methylumbelliferyl-N- 
acetylneuraminic acid (not shown). In contrast,  there was 
no sialylation of radiolabded lactose when c~(2-6)-sialyllactose, 
colominic acid [poly-c~(2-8)-neuraminic acid], N-acetylneura- 
minic acid, or c~(2-9)-sialylsialyUactose were used as sialic acid 
donors (Fig.  2). 
Next, various saccharides were assayed for their ability to 
inhibit  sialic  acid transfer by  T  cruzi  and  T.  brucei trans- 
sialidases.  The addition of saccharides containing B-linked, 
but not ol-linked, galactopyranosyl residues reduced the transfer 
of sialic  acid  to  radiolabeled  lactose  (Table 4).  B-methyl- 
galactose, but not c~-methylgalactose, also inhibited the reac- 
tion. Gal(B1-4)-[Fuc(c~l-3)]Glc  had an intermediate inhibi- 
tory activity on the formation of radiolabeled sialyllactose by 
both enzymes, when compared with the other disaccharides 
(Table 4). The dose-response curves comparing Gal(B1-4)Glc 
(lactose) with Gal(otl-6)Glc (melibiose), and IS-methyl- with 
c~-methyl-galactose, showed that B-linked galactopyranosyl 
residues are at least  100 times more efficient in inhibiting 
the reaction than c~-linked  residues (Fig.  3). 
To distinguish between competitive inhibition due to sialy- 
lation of cold saccharides and inhibition of catalysis,  selected 
saccharides  were incubated with [3H]sialyUactose in the pres- 
ence of purified enzyme. The formation of new sialylated 
molecules was revealed by TLC on silica-gel plates, followed 
by fluorography. This experiment documented the sialyla- 
tion of Gal(IS1-6)Gal  and IS-methylgalactose (Fig. 4, lanes b 
and c) and, to a minor extent, of melibiose (Fig. 4, lane d). 
The lower efficiency of sialylation of melibiose was associated 
with an increased production of free sialic acid. Therefore, 
similarly to the T. cruzi enzyme, the sialidase activity increases 
in the absence of good sialic  acid acceptors. 
Absence of Reactivity of the Trans.sialidase with T, cruzi-specific 
Monodonal and Polyclonal Antibodies.  To reveal a possible im- 
munological crossreactivity between the T. brucei and T cruzi 
enzymes, we attempted to immunoprecipitate the  T. brucei 
Table  4.  Effect  of Potential Acceptors  or Inhibitors  on  T.  brucei and  T.  cruzi  Trans-sialidase  Activities 
Nonradioactive saccharide added to reaction  mixture* 
Reduction in sialyl-'4C-lactose formation 
with trans-sialidase purified ffom:* 
Chemical composition  Name  T. brucei  T. cruzi 
% 
Gal(l~l-4)Glc  Lactose  86s  96 
Gal(131-6)Ga!  -  51  90 
Gal(cxl-6)Gal(c~l-6)Glc  Stachyose  - 7  - 24 
(fll-2)Fru 
Gal(c~ 1-6)G1c  Melibiose  0  9 
tS-Methyl-Gal  -  44  60 
c~-Methyl-Gal  -  11  5 
Gal(131-4)[Fuc(cd-3)]Glc  -  29  54 
* Nonradioactive  saccharides were added at a final concentration of 8 mM in a standard assay for trans-sialidase activity (1 mM sialyllactose and 
7.2 nM 14C-lactose in 50/~1 of 20 mM Hepes buffer,  pH 7). 
# Trans-sialidase was purified from trypomastigotes  by Con A af~nity chromatography  as described in Table 3. 
S Percentage of reduction in cpm in relation to reactions carried out without nonradioactive saccharides (5,532 cpm for the T. brucei enzyme, 4,513 
for the T. cmzi enzyme). All samples were assayed in duplicates, and the background value (72 cpm, obtained in the absence of trans-sialidase) was 
subtracted.  Variation between the duplicate values was in every case <16% of the mean. 
470  A Novel Trans-sialidase of Trypanosoma brucei o= 
L9 
I 
o 
100  ~176 
80 
6O 
40 
20 
0.8  8  80 
B 
0 
/ 
9 
I  I 
o -//o!~  .  ~o 
Inhibitor  concentration  (mM) 
Figure  3.  Inhibition ofsialylation  ofradiohbeled lactose by saecharides. 
[14C]Lactose (7.2/zM), sialyLlactose  (1 mM), and the indicated amounts 
of nonradioactive saccharides were incubated with T  bruce/(filled symbols) 
or T cmzi (own symbo/s)  trans-sialidases. Radioactivity  associated with sialic 
acid was separated by anion-exchange  chromatography and measured in 
a/3 counter. Trans-sialidases were purified from NP-40 trypomastigote ly- 
sates by Con A affinity chromatography.  (A) Lactose (circles) and melibiose 
(triangles). (B) fl-methyl-galactose (circles)  and ,v-methyl-galactose (triangles). 
trans-sialidase activity with monoclonal and polyclonal anti- 
bodies  specific for  T  cruzi  trans-sialidase.  Even when used 
in amounts 4.5-9-fold  higher than that necessary to immu- 
noprecipitate an equally active T  cruzi trans-sialidase prepa- 
ration,  the antibodies  failed  to  remove  T  brucei enzymatic 
activity  (Fig.  5). 
Identification of  Procyclin as a Sialic Acid Acceptor.  To iden- 
tify the  sialic  acid  acceptor(s)  on  the  T.  brucei surface,  live 
procyclic  trypomastigotes  were incubated with [3H]sialyllac- 
tose.  Fluorography of an SDS-PAGE gel carried  out with a 
lysate  of these  parasites  showed  only  one radioactive  band 
(Fig. 6, lane d). Sialidase treatment of the lysate removed the 
radioactivity from the band (Fig. 6, lane e), while treatment 
with control buffer had little effect (Fig. 6, lane  f), indicating 
that the sialic acid was covalently bound to surface molecules. 
Figure 4.  TLC on silica  gel ofdifferent 
saccharides sialylated by T  bruce/trans- 
sialidase.  100  nmol of lactose  (lane a), 
/3-methylgalactose (lane b), Gal(/31-6)Gal 
(lane c), or mdibiose (lane d) was incubated 
with 15 nmol of [sialic-9-3H]sialyllactose 
in the presence of T bruce/trans-sialidase 
(purified by Con A  affinity and anion- 
exchange chromatographies)  for 210 min 
at room temperature. The products of the 
reaction were isolated by dution from a 
QAE-Sephadex column and analyzed by 
chromatography on silica gel, followed 
by fluorography.  The arrows indicate the 
positions of free sialic acid (bottom)  and 
sialyllactose (top). 
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Lack of reactivity of T  bruce/trans-sialidase  with antibodies 
to T cruzi trans-sialidase. T bruce/(filled symbols) or T cruzi (open symbols) 
NP-40 lysates were immunoprecipitated  with the indicated  volumes of pro- 
tein A--agarose  beads bearing T. cruz/antibodies. The total volume of agamse 
beads was always brought to 27 #1 by the addition of noncoated beads. 
(.4) Immunoprecipitation with the anti-T cruz/trans-sialidase mAb 39. 
(B) Immunoprecipitation with rabbit antibodies against purified T. cruzi 
trans-sialidase (circles) or with rabbit antibodies against a synthetic peptide 
corresponding to the first  19 NH2-terminal amino acid residues  of the 
T.  cruzi trans-sialidase  (triangles). 
This band had the same molecular mass, intensity, and shape 
expected  of a procyclin band (Fig.  6,  lanes a-c) and reacted 
with a procyclin-specific  mAb in Western blotting  (Fig.  6, 
lane g). 
An  extract  prepared  with  [3H]sialyllactose-labeled  para- 
sites was then immunoprecipitated with an antiprocyclin mAb. 
Most counts were immunoprecipitated,  whereas no radioac- 
tivity  was precipitated  by  a control  mAb  (Table  5). 
Discussion 
Here we report the isolation and characterization  of a trans- 
sialidase in T  brucei. The enzymatic activity is stage specific: 
it is detected in the procyclic insect forms, but not on slender 
or stumpy blood-stage  trypomastigotes.  It is likely that the 
enzyme is expressed only during the transformation of the 
blood stages into procydics in the insect midgut, but it cannot 
Figure 6.  SDS-PAGE  of T./~u- 
cei surface molecules sialylated by 
the addition of radiohbded sialyl- 
lactose.  Live  T  bruce/ procyclic 
trypomastigotes were incubated 
with  [3H]sialyLlactose and lysed 
with NP-40. Lysate samples were 
untreated (lanes a and d), treated 
with sialidase (lanes b and e), or 
treated with sialidase buffer  (lanes c and f) and then subjected  to SDS- 
PAGE. The gel was impregnated with sodium salicylate and stained with 
coomassie blue (lanes a-c). The presence of radioactive molecules in the 
same gel was revealed by fluorography (lanes d-f).  A lysate sample was 
subjected to Western blotting using an antiprocyclin mAb (lane g). The 
positions of molecular mass  standards  are shown on the left. 
471  Pontes  de Carvalho et al. Table  5.  Immunoabsorption with Procyclin-specific mAb of Molecules Sialylated by the Incubation of Live  T.  brucei Procyclic 
Trypomastigotes with [3H]Sialyllactose 
mAb used in immunoabsorption*  Counts  in supernatant  Counts in pellet 
cpm  +_ SD  %  cpm  +_ SD  % 
137'  3,755  _+ 461  28.1  9,618  _+ 709  71.9 
3C9S  15,293  _+ 696  99.8  28  _+ 8  0.2 
Trypomastigotes were incubated for 28 min with sialic-9-[3H](cx2-3)-sialyllactose,  washed six times with cold BSM-G, and lysed with NP-40. 
" Lysates (60-/,1 fractions) were incubated with 20/~g of the indicated mAb adsorbed to 20/zl of protein A-agarose, in quadruplicate. The beads 
were washed three times, centrifuged, and the amount of radioactivity  in pallets or supernatants was measured. 
* Procyclin-specific,  IgG1 mAb. 
S Unrdated IgG1 mAb. 
be excluded that an inactive form of trans-sialidase  is already 
present in the blood stages. Extracts of procyclics pretreated 
with pronase had diminished enzymatic activity, indicating 
that most of the enzyme is associated with the surface mem- 
brane of the parasites. 
The trans-sialidase  was purified by Con A  affinity chro- 
matography, followed by ion exchange and molecular sieving 
chromatography on FPLC. The activity of the purified en- 
zyme was not affected by treatment with proteinase K. It 
is not clear whether proteinase K does not cleave the enzyme, 
or releases an enzymatically active fragment of the protein. 
SDS-PAGE and silver staining of the purified enzyme under 
nonreducing conditions revealed a single band of 63 kD, but 
under reducing conditions additional bands between 63 and 
73 kD were also detected. Further investigation is necessary 
to determine whether some of these bands are contaminants, 
incompletely reduced molecules, products of different trans- 
sialidase  genes,  or represent differences in postranslational 
modifications of a single polypeptide. By molecular sieving 
chromatography the apparent molecular mass of the active 
fractions varied considerably in different experiments, ranging 
from 66 to >700 kD, but we did not detect significant differ- 
ences in the enzymatic activities of the monomeric and oligo- 
meric forms. In T. cruzi,  the trans-sialidaseAialidase  is also 
multimeric (19, 20), the monomers varying from 120 to 180 
kD  in  the  cell-derived, bloodstream-like  trypomastigotes 
(10, 19,  20)  to 90 kD in the insect stages  (L.  B.  Chaves, 
M. R. P,. Briones, and S. Schenkman, manuscript submitted 
for publication). 
The properties of the trans-sialidases of T. cruzi and T. brucei 
are similar.  Both enzymes catalyse the transfer of ol(2-3)-, 
but not ol(2-6)-,  ol(2-8)-,  or ot(2-9)-linked sialic acid, and 
are equally inhibited by 10 gM mercuric acetate or cupric 
nitrate (not shown). In both instances sialic acid is readily 
transferred to terminal B-galactopyranosyl residues (26; this 
paper). Terminal o~-galactopyranosyl residues are at least 100 
times less efficient acceptors (Fig. 3). Nevertheless, it appears 
that melibiose [Gal(o~l-6)Glc] can be sialylated if it is present 
in large excess in the incubation mixture (Fig.  4,  lane d). 
By TIC we did not detect any contaminants in the melibiose 
preparation, but we cannot exclude the possibility of a minor 
contaminant saccharide. 
During the purification procedure, all fractions with trans- 
sialidase activity also had sialidase activity, as measured by 
the 4-methylumbelliferyl-N-acetylneuraminic  acid assay (not 
shown). The observation that sialidase activity was inhibited 
by the presence of efficient acceptors (Fig. 4, lanes a-c) argues 
that the same enzyme displays both activities. It is well known 
that glycosidases can function as trans-glycosidases, depending 
on the relative affinity of the glycosyl residues for the saccha- 
ride acceptors or for water. In fact, a cloned gene product 
from T. cruzi has been shown to display both trans-sialidase 
and sialidase activities,  depending on the presence or absence 
of appropriate acceptors in the incubation medium (27).  It 
is very likely that, in the presence of the blood meal in the 
tsetse fly midgut, the transfer reaction will predominate and 
molecules on the parasite surface will be sialylated. 
It appears that procyclin is the major (if not only) protein 
sialylated by the enzyme. One sialylated band was seen on 
SDS-PAGE of whole parasite lysates, and the position of the 
band coincided with that of procyclin. Moreover, mAbs to 
procyclin immunoprecipitate most of the sialylated molecules 
of the parasite surface membrane. This finding is agreement 
with recent data documenting the presence of sialic acid in 
the GPI anchor of procyclin (ga). The finding of sialic acid 
in supernatants of live trypomastigotes treated with pronase 
suggests that other N-linked or O-linked procyclin saccha- 
rides may also be sialylated. 
T.  brucei procyclics  contain larger amounts of sialic acid 
than cell-derived T. cruzi trypomastigotes, but the saccharide 
density on the plasma membrane of the parasites  may not 
be different, since by light microscopy the procyclics are much 
larger than  T. cruzi trypomastigotes. Assuming that there 
are as many procyclin as VSG molecules (107) per parasite 
(28),  and that procyclin is the only sialylated molecule, we 
calculate that there are ",~10 sialic acid residues per procyclin 
molecule. 
What is the function of the trans-sialidase?  In T. cruzi the 
membrane-associated sialylated epitope, Ssp-3, appears to be 
involved in  cell  adhesion  and  penetration  (10).  Procyclic 
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cells  (or with the peritrophic  membrane)  during  their on- 
ward migration  to the proboscis, and penetration  into the 
salivary glands.  Perhaps the procyclin sialic acid, and tsetse 
lectins (29),  are involved in these hypothetical interactions. 
Another possible function of the procyclin sialic acid relates 
to the complement system. In the blood stages,  it has been 
postulated that VSG protects the parasite from the cascade 
(1, 30). The transformation  of blood stages into procyclics, 
and the gradual substitution of VSG by procyclin (4, 5), occurs 
in the insect midgut in the presence of the blood meal and 
perhaps of an active complement system. This process takes 
12-48 h  (4,  5), and it is conceivable that  during  this time 
the cascade is activated, leading to the deposition of C3b on 
the parasite.  The high concentration of sialic acid on the para- 
site  surface  should  increase  the  avidity  of factor  H  for 
membrane-bound  C3b,  and  prevent  the  assembly of C3- 
convertase  (31,  32).  Sialic  acid  could  also  mask  terminal 
~/-galactopyranosyl  residues  (33)  on  the  parasite  surface, 
preventing recognition of the surface components by mam- 
malian (natural?) antibodies. These hypotheses are amenable 
to experimental  verification. 
While this paper was being prepared for publication, a pro- 
tein of T. brucei procyclic trypomastigotes with sialidase  ac- 
tivity was reported (34). This sialidase and the trans-sialidase 
here described may be the same enzyme since they have similar 
physico-chemical properties  and substrate  specificities. 
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